August 2017

A community oncologist's perspective on the advantages and challenges with precision medicine.

A reaction to Institute for Clinical and Economic Review's value assessment framework by Eleanor M. Perfetto, PhD, MS, of The National Health Council.

Collaborating with diverse stakeholders, including the FDA and the Surveillance, Epidemiology, and End Results program, CancerLinQ continues its efforts to harness big data to rapidly improve the quality of care for people with cancer.

Syapse improves patient outcomes by providing workflow solutions that enable cancer care providers to deliver precision medicine within their organization, Ken Tarkoff, the company's CEO, told Evidence-Based Oncologyâ„¢.

Genetic counselors (GCs) increasingly serve a variety of roles across the healthcare spectrum, including test utilization management. Our data show that utilizing the expertise of GCs reduced test order errors, improved patient outcomes, and resulted in significant cost savings to the healthcare system.

As we shift to the precision-medicine model of cancer care, it is essential to develop a scalable system that can deliver these care solutions in a patient-centered, economically sustainable way.

The Bonnie Addario Lung Cancer Foundation has developed a registry that can serve as a repository for data on patients with lung cancer-a means to empower patients and assist care providers to deliver personalized medicine in a patient-centered manner.

Precision medicine is increasingly being utilized in oncology. Aurora Health Care has implemented Syapse software to integrate molecular data into the electronic health record to accommodate precision medicine findings.

AJMC®TV interviews let you catch up with experts on what’s new and important about changes in healthcare. The interviews provide insights from key decision makers-from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. You can access the video clips at ajmc.com/interviews.

An update on the latest developments in the world of oncology care: product approvals, clinical developments, health policy changes, and more.